Abstract
Chemical shift imaging (CSI) provides valuable information for assessing the bone marrow, while adding little to total examination time. In this article, we review the uses of CSI for evaluating bone marrow abnormalities. CSI can be used for differentiating marrow-replacing lesions from a range of non-marrow-replacing processes, although the sequence is associated with technical limitations and pitfalls. Particularly at 3 T, susceptibility artefacts are prevalent, and optimal technical parameters must be implemented with appropriate choices for echo times.
Original language | English (US) |
---|---|
Pages (from-to) | 648-657 |
Number of pages | 10 |
Journal | Clinical Radiology |
Volume | 69 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2014 |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging